These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3929239)

  • 1. Selective inhibition by fenflumizole tissue cyclooxygenase in rabbits ex vivo.
    Basista M; Grodzińska L; Gryglewski RJ
    Pol J Pharmacol Pharm; 1985; 37(1):41-6. PubMed ID: 3929239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenflumizole: interactions with the arachidonic acid cascade.
    Corell T; Hasselmann G; Splawinski J; Wojtaszek B
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):297-303. PubMed ID: 6417973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prostaglandin and thromboxane system of the gastric mucosa as a target for protective and ulcerogenic drugs].
    Peskar BM
    Wien Klin Wochenschr; 1984 Feb; 96(4):133-8. PubMed ID: 6585091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fenflumizole on aggregation ex vivo of human platelets and formation of thromboxane B2 and 6-keto-prostaglandin-F1 alpha.
    Vinge E; Corell T; Andersson KE
    Eur J Clin Pharmacol; 1984; 26(6):711-7. PubMed ID: 6436029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of repeated oral doses of fenflumizole on platelet aggregation and thromboxane formation in man ex vivo.
    Dahl-Puustinen ML; Corell T; Koch K; Puustinen T
    Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):101-6. PubMed ID: 3357910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of anti-platelet agents].
    Lecompte T; Kher A; Gaillard JL; Samama M
    J Mal Vasc; 1983; 8(1):3-16. PubMed ID: 6302191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of non-steroidal anti-inflammatory drugs on the in vivo synthesis of thromboxane and prostacyclin in humans.
    Drvota V; Vesterqvist O; Gréen K
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():153-6. PubMed ID: 1825533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.
    Chang GT; Kang SK; Kim JH; Chung KH; Chang YC; Kim CH
    J Ethnopharmacol; 2005 Dec; 102(3):430-9. PubMed ID: 16125889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single Ditazole dose on platelet aggregation and prostaglandin formation.
    Prisco D; Bartoletti A; Lombardi A
    Int J Clin Pharmacol Res; 1984; 4(2):129-36. PubMed ID: 6147319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

  • 13. Eicosanoid balance at early stages of experimental atherosclerosis. Its relationship with plasma fibrinolytic activity and platelet aggregation.
    Korbut R; Zmuda A; Basista M; Gryglewski RJ
    Agents Actions Suppl; 1986; 20():225-36. PubMed ID: 3544742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different sensitivity of basilar and saphenous arteries to thromboxane A2-induced contractions. Effect of imidazole 2-hydroxybenzoate (ITF 182).
    Pagella PG; Agozzino S; Bellavite O; Donà GC; Mendola N
    Arzneimittelforschung; 1984; 34(11):1514-6. PubMed ID: 6596952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet effects of fenflumizole, a new anti-inflammatory drug, in dogs.
    Nabata H; Uchino M; Okazaki A; Sakai K
    Jpn J Pharmacol; 1987 May; 44(1):97-100. PubMed ID: 3626187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fenflumizole on platelet aggregation in man.
    Grande P; Wadt J; Corell T
    Eur J Clin Pharmacol; 1984; 27(2):169-72. PubMed ID: 6437841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.